Chase M. Webb

Chase M. Webb

Auto-generated profile, based on publicly available information

Chase M. Webb

Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SVSeth F. Vigneron
Seth F. Vigneron
SOShohei Ohno
Shohei Ohno
JBJoao Braz
Joao Braz
JKJoseph Y. Kim
Joseph Y. Kim
OKOh Sang Kweon
Oh Sang Kweon
BSBrian K. Shoichet
Brian K. Shoichet
Large library docking of tangible molecules has revealed potent ligands across many targets. While make-on-demand libraries now exceed 75 billion enumerated molecules, their synthetic routes are dominated by a few reaction types, reducing diversity and inevitably leaving many interesting bioactive-like chemotypes unexplored. Here, we investigate the large-scale enumeration and targeted docking of isoquinuclidines. These “natural-product-like” molecules are rare in the current libraries and are functionally congested, making them interesting as receptor probes. Using a modular, four-component reaction scheme, we built and docked a virtual library of over 14.6 million isoquinuclidines against both the µ- and κ -opioid receptors (MOR and KOR, respectively). Synthesis and experimental testing of 18 prioritized compounds found nine ligands with low µM affinities. Structure-based optimization revealed low- and sub- nM antagonists and inverse agonists targeting both receptors. Cryo-electron microscopy (cryoEM) structures illuminate the origins of activity on each target. In mouse behavioral studies, a potent member of the series with joint MOR-antagonist and KOR-inverse-agonist activity reversed morphine-induced analgesia, phenocopying the MOR-selective anti-overdose agent naloxone. Encouragingly, the new molecule induced less severe opioid-induced withdrawal symptoms compared to naloxone during withdrawal precipitation, and did not induce conditioned-place aversion, likely reflecting a reduction of dysphoria due to the compound’s KOR-inverse agonism. The strengths and weaknesses of bespoke library docking, and of docking for opioid receptor polypharmacology, will be considered.

28 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MHMichael D. Holsey
Michael D. Holsey
ABAlexey Bondar
Alexey Bondar
PGPeter Geggier
Peter Geggier
GDGeorge V. Dukas
George V. Dukas
CWChase M. Webb
Chase M. Webb
JJJonathan A. Javitch
Jonathan A. Javitch
SUMMARY: The extent to which local GPCR surface density governs engagement of downstream signaling and trafficking pathways remains unclear. Using single-particle tracking of the μ-opioid receptor (MOR), we show that receptor density differentially regulates G protein signaling and GRK2/3–β-arrestin–dependent receptor trafficking. At low surface density, MORs activate G proteins but fail to enter clathrin-coated structures despite the presence of endogenous GRK2/3 and β-arrestin. Increasing MOR density, co-expressing other class A GPCRs, or elevating GRK2 or β-arrestin abundance rescues agonist-induced MOR trafficking. In contrast, the class B GPCR V2R blocks MOR trafficking at both low and high MOR densities. These results support a model in which increasing class A GPCR density, despite worsening effector-to-receptor stoichiometry, promotes trafficking by forming an affinity matrix that enables reversible GRK2/3 and β-arrestin interactions to be productively used by neighboring receptors in a density-dependent manner, whereas class B GPCRs sequester β-arrestin and block trafficking.